We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

218 hedge funds and large institutions have $1.13B invested in Amphastar Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 82 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $2.23M | Put options by funds: $581K

48% more capital invested

Capital invested by funds: $764M → $1.13B (+$368M)

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

2.76% more ownership

Funds ownership: 60.3% → 63.06% (+2.8%)

2% more funds holding

Funds holding: 213 → 218 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 82

Holders
218
Holders Change
+5
Holders Change %
+2.35%
% of All Funds
3.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
76
Reduced
82
Closed
26
Calls
$2.23M
Puts
$581K
Net Calls
+$1.65M
Net Calls Change
+$628K

Top Buyers

1
GIP
Granite Investment Partners
California
+$17.6M
2
Neuberger Berman Group
Neuberger Berman Group
New York
+$14.1M
3
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$10.2M
4
Millennium Management
Millennium Management
New York
+$8.07M
5
Bank of America
Bank of America
North Carolina
+$7.4M

Top Sellers

1
BlackRock
BlackRock
New York
-$15.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.5M
3
Pacer Advisors
Pacer Advisors
Pennsylvania
-$6.47M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$3.01M
5
Morgan Stanley
Morgan Stanley
New York
-$2.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
201
Parallel Advisors
California
$3.56K +$2.69K +82 +631%
GWS
202
Glassman Wealth Services
Virginia
$3.45K – – –
CAL
203
Capital Advisors Ltd
Ohio
$3K +$492 +15 +20%
FFA
204
Farther Finance Advisors
California
$2.63K – – –
LC
205
Lindbrook Capital
California
$2.02K +$393 +12 +29%
C
206
Covestor
United Kingdom
$2K +$852 +26 +137%
FMII
207
Farmers & Merchants Investments Inc
Nebraska
$1.05K – – –
FSWA
208
Financial Synergies Wealth Advisors
Texas
$563 – – –
BIA
209
Bell Investment Advisors
California
$563 +$492 +15 New
BAM
210
Belpointe Asset Management
Nevada
$563 +$492 +15 New
GRP
211
Global Retirement Partners
California
$399 – – –
ECM
212
Everence Capital Management
Indiana
$243 +$212K +6,470 New
SC
213
Schubert & Co
Texas
$113 +$66 +2 +200%
JWA
214
JFS Wealth Advisors
Pennsylvania
$75 -$66 -2 -50%
DI
215
Disciplined Investments
Oklahoma
$75 – – –
AF
216
Advisornet Financial
Minnesota
$38 – – –
SIC
217
SJS Investment Consulting
Ohio
$38 – – –
Pacer Advisors
218
Pacer Advisors
Pennsylvania
– -$6.47M -231,009 Closed
Qube Research & Technologies (QRT)
219
Qube Research & Technologies (QRT)
United Kingdom
– -$1.72M -61,271 Closed
Schroder Investment Management Group
220
Schroder Investment Management Group
United Kingdom
– -$1.24M -44,326 Closed
TC
221
TwinBeech Capital
New York
– -$1.23M -43,937 Closed
Acadian Asset Management
222
Acadian Asset Management
Massachusetts
– -$668K -23,870 Closed
OQS
223
Occudo Quantitative Strategies
Florida
– -$650K -23,213 Closed
SO
224
STRS Ohio
Ohio
– -$512K -18,300 Closed
XT
225
XTX Topco
Cayman Islands
– -$462K -16,480 Closed
6 7 8
9
10

AMPH Hedge Fund Activity: Q1 2023 in Review

218 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q1 2023, worth a combined $1.13B — up 48% from $764M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new AMPH positions and 26 closed out — a net gain of 6 holders — while 76 added to existing stakes and 82 trimmed.

The largest buyer was Granite Investment Partners, opening a new position worth an estimated $17.6M. The largest seller was BlackRock, cutting an estimated $15.5M.

  • 218 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q1 2023, up from 213 in Q4 2022.
  • Funds reported $1.13B of Amphastar Pharmaceuticals stock for Q1 2023, up 48% quarter-over-quarter.
  • 32 funds opened new Amphastar Pharmaceuticals positions in Q1 2023 and 26 closed out, a net change of +6 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q1 2023 was Granite Investment Partners, an estimated $17.6M added.
  • The largest Amphastar Pharmaceuticals seller in Q1 2023 was BlackRock, an estimated $15.5M sold.

Based on aggregated 13F filings for Q1 2023.